Temporal trend in relative risk of second primary colorectal cancer

American Journal of Gastroenterology

Volumn 101, Issue 6, 2006, Pages 1342-1347

  Das, Ananya ^a,c   Chak, Amitabh ^b   Cooper, Gregory S ^b  

^a MAYO CLINIC   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Gastroenterology and Hepatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CANCER; FEMALE; FOLLOW UP; GENDER; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; RISK FACTOR; SECOND CANCER; SURVIVAL RATE;

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POISSON DISTRIBUTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 33744811748     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00580.x     Document Type: Article

References (27)

1. Hemminki K Li X Dong C. Second primary cancers after sporadic and familial colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001 10 : 793 8.
2. Yamazaki T Takii Y Okamoto H, et al. What is the risk factor for metachronous colorectal carcinoma? Dis Colon Rectum 1997 40 : 935 8.
3. Enblad P Adami HO Glimelius B, et al. The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer 1990 65 : 2091 100.
4. NCCN colon cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 2003 1 : 40 53.
5. NCCN rectal cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 2003 1 : 54 63.
6. Figueredo A Rumble RB Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: A practice guideline. BMC Cancer 2003 3 : 26 26.
7. ESMO. ESMO minimum clinical recommendations for diagnosis adjuvant treatment and follow-up of colon cancer. Ann Oncol 2001 12 : 1053 4.
8. Benson AB 3rd. Desch CE Flynn PJ, et al. 2000 Update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000 18 : 3586 8.
9. Smith RA Cokkinides V von Eschenbach AC, et al. American Cancer Society guidelines for early detection of cancer. CA Cancer J Clin 2002 52 : 8 22.
10. Berman JM Cheung RJ Weinberg DS. Surveillance after colorectal cancer resection. Lancet 2000 355 : 395 9.
11. Winawer S Fletcher R Rex D, et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale - update based on new evidence. Gastroenterology 2003 124 : 544 60
12. Surveillance, Epidemiology, and End Results (SEER) Program http://www.seer.cancer.gov SEER* Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2004 Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission.
13. Percy C Van Holten VV Muir C, eds. International classification of diseases for oncology, 2nd Ed. Geneva : World Health Organization, 1990.
14. Breslow NE Day NE. Statistical methods in cancer research. Volume II-the design and analysis of cohort studies. IARC Sci Publ 1987 82 : 1 406.
15. Schoenberg BS Myers MH. Statistical methods for studying multiple primary malignant neoplasms. Cancer 1977 40 : 1892 8.
16. Zhang MJ. Cox proportional hazards regression model for analysis of survival data in cancer research. Cancer Treat Res 2002 113 : 59 70.
17. Jemal A Murray T Ward E, et al. Cancer Statistics, 2005. CA Cancer J Clin 2005 55 : 10 30.
18. Schoemaker D Black R Giles L, et al. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998 114 : 7 14
19. Pfister DG Benson AB 3rd. Somerfield MR. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med 2004 350 : 2375 82.
20. Cooper GS Yuan Z Chak A, et al. Patterns of endoscopic follow-up after surgery for nonmetastatic colorectal cancer. Gastrointest Endosc 2000 52 : 33 8.
21. Cooper GS Yuan Z Chak A, et al. Geographic and patient variation among Medicare beneficiaries in the use of follow-up testing after surgery for nonmetastatic colorectal carcinoma. Cancer 1999 85 : 2124 31.
22. Winawer SJ Zauber AG Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993 329 : 1977 81.
23. Green RJ Metlay JP Propert K, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: An analysis of Intergroup 0089. Ann Intern Med 2002 136 : 261 9.
24. Knopf KB Warren JL Feuer EJ, et al. Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries. Gastrointest Endosc 2001 54 : 563 71.
25. Lynch HT de la Chappel A. Hereditary colorectal cancer. N Engl J Med 2003 : 348 : 919 32.
26. Weinberg DS Newschaffer CJ Topham A. Risk for colorectal cancer after gynecologic cancer. Ann Intern Med 1999 131 : 189 93.
27. Das A Neugut AI Cooper GS, et al. Association of ampullary and colorectal malignancies. Cancer 2004 100 : 524 30.